High-dose therapy and autologous stem-cell transplantation in waldenstrom macroglobulinemia: the lymphoma working party of the european group for blood and marrow transplantation
- Kyriakou, C
- Canals, C
- Sibon, D
- Cahn, Y
- Kazmi, M
- Kolbe, K
- Gorin, N
- Thomson, K
- Milpied, N
- Niederwieser, D
- Indrak, K
- Corradini, P
- Sureda, A
- Schmitz, N.
- ARCESE, WILLIAM
Publication date
January 2010
DOI Publisher
American Society of Clinical Oncology (ASCO)Abstract
Purpose The role of autologous stem-cell transplantation (ASCT) in Waldenström macroglobulinemia (WM) is not defined. The aim of this study was to analyze the results of ASCT in patients with WM and to determine the prognostic factors that have a significant impact on outcome
Add to ORKG